The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients

Biomedicine and Pharmacotherapy

Volumn 67, Issue 2, 2013, Pages 172-178

  Nanni, Cristina ^a   Zompatori, Maurizio ^a   Ambrosini, Valentina ^a   Montesi, Valeria ^a   Mezzetti, Simona ^a   Ferretti, Alice ^b   Chondrogiannis, Sotirios ^b   Rubello, Domenico ^b   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Santa Maria della Misericordia Hospital   (Italy)

Author keywords

Contrast enhanced CT (ceCT); Diagnostic improvement; Hybrid PET CT systems; Low dose CT; PET ceCT examination

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOMEPROL;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERMETABOLISM; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NUCLEAR MEDICINE TECHNICIAN; PHYSICIAN; PRIORITY JOURNAL;

CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 84875376519     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.12.003     Document Type: Article

References (12)

1. Aschoff P., Plathow C., Beyer T., Lichy M.P., Erb G., Oksüz M.O., et al. Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging. Eur J Nucl Med Mol Imaging 2012, 39(2):316-325.
2. Beyer T., Antoch G., Bockisch A., Stattaus J. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. J Nucl Med 2005, 46(3):429-435.
3. Yau Y.Y., Chan W.S., Tam Y.M., Vernon P., Wong S., Coel M., et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?. J Nucl Med 2005, 46(2):283-291.
4. Lacout A., Marcy P.Y., Thariat J. Value of combined PET/contrast-enhanced high-resolution CT fusion imaging for lung cancer. AJR Am J Roentgenol 2012, 198(1):W99.
5. Mayerhoefer M.E., Schuetz M., Magnaldi S., Weber M., Trattnig S., Karanikas G. Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?. Eur Radiol 2012, 22(4):938-946.
6. Krabbe C.A., Balink H., Roodenburg J.L., Dol J., de Visscher J.G. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx. Int J Oral Maxillofac Surg 2011, 40(11):1263-1270.
7. Allen T.L., Kendi A.T., Mitiek M.O., Maddaus M.A. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2011, 23(1):43-50.
8. Kitajima K., Suzuki K., Senda M., Kita M., Nakamoto Y., Sakamoto S., et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?. Ann Nucl Med 2011, 25(7):511-519.
9. Miles K.A., Williams R.E., Yu D., Griffiths M.R. Demonstrating intertumoural differences in vascular-metabolic phenotype with dynamic contrast-enhanced CT-PET. Int J Mol Imaging 2011, 2011:679473.
10. Ouvrier M.J., Diologent B., Edet-Sanson A., Callonnec F., Hitzel A., Pesquet A.S., et al. Influence of PET/CT on radiologists and contrast-enhanced CT on nuclear medicine physicians in patients with lymphoma. Q J Nucl Med Mol Imaging 2011, 55(3):324-333.
11. King K.G., Kositwattanarerk A., Genden E., Kao J., Som P.M., Kostakoglu L. Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting. Radiographics 2011, 31(2):355-373.
12. Pfluger T., Melzer H.I., Schneider V., La Fougere C., Coppenrath E., Berking C., et al. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT. Eur J Nucl Med Mol Imaging 2011, 38(5):822-831.